المؤلفون: Song Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Zhang B; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Xin D; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Kou X; Department of Medical Oncology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China., Tan Z; Department of Thoracic Surgery, Xingtai People's Hospital, Xingtai, China., Zhang S; Department of Gastrointestinal Oncology, Shandong First Medical University Cancer Hospital, Shandong Cancer Hospital, Jinan, China., Sun M; Department of Medical Oncology, Central Hospital Affiliated to Shandong First Medical University, Jinan, China., Zhou J; Department of Medical Oncology, Sichuan Cancer Hospital, Chengdu, China., Fan M; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Zhang M; Department of Integrated Traditional and Western Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China., Song Y; Department of Thoracic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, China., Li S; Department of Medical Oncology, Anhui Provincial Cancer Hospital, Hefei, China., Yuan Y; Department of Medical Oncology, Xuzhou Central Hospital, Xuzhou, China., Zhuang W; Department of Medical Oncology, Fujian Cancer Hospital, Fuzhou, China., Zhang J; Medical Oncology Department of Gastrointestinal Cancer, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Shenyang, China., Zhang L; Department of Oncology, Chongqing University Three Gorges Hospital, Chongqing, China., Jiang H; Department of Radiation Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, China., Gu K; Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, China., Ye H; Department of Medical Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China., Ke Y; Shanghai Henlius Biotech, Inc., Shanghai, China., Li J; Shanghai Henlius Biotech, Inc., Shanghai, China., Wang Q; Shanghai Henlius Biotech, Inc., Shanghai, China., Zhu J; Shanghai Henlius Biotech, Inc., Shanghai, China., Huang J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. huangjingwg@163.com.

مؤلفون مشاركون: ASTRUM-007 investigators

المصدر: Nature medicine [Nat Med] 2023 Feb; Vol. 29 (2), pp. 473-482. Date of Electronic Publication: 2023 Feb 02.

نوع المنشور: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Esophageal Neoplasms* , Esophageal Squamous Cell Carcinoma*/chemically induced , Esophageal Squamous Cell Carcinoma*/drug therapy, Humans ; Antibodies, Monoclonal/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; B7-H1 Antigen/therapeutic use ; Cisplatin ; Double-Blind Method